Page last updated: 2024-10-29

ketoconazole and Local Neoplasm Recurrence

ketoconazole has been researched along with Local Neoplasm Recurrence in 14 studies

1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.

Research Excerpts

ExcerptRelevanceReference
"Liarozole is a new imidazole that is also effective in second-line therapy for prostatic cancer and has fewer side effects."3.77Ketoconazole and liarozole in the treatment of advanced prostatic cancer. ( Denis, L; Mahler, C; Verhelst, J, 1993)
"Cushing disease is most frequently caused by pituitary adenomas that secrete adrenocorticotrophic hormone."2.44Management of recurrent and refractory Cushing disease. ( Aghi, MK, 2008)
"Prostate cancer is the most frequently diagnosed cancer and the second leading cause of cancer death in men, following lung cancer."2.42Clinical strategies in the management of biochemical recurrence after radical prostatectomy. ( Culkin, DJ; Zimmerman, RA, 2003)
"Cushing syndrome is a rare endocrine disorder."1.91An exceptionally rare case of Cushing's syndrome caused by ectopic ACTH syndrome due to olfactory neuroblastoma in childhood. ( Gülten, G; Özhan, B; Yalçın, N; Yıldırım Çakar, D, 2023)
"Unfortunately the patient died of respiratory failure due to metastasis."1.37[Bilateral conjunctival oedema as a symptom of adrenal adenocarcinoma]. ( Montes-Mollón, MÁ; Paz Moreno-Arrones, J, 2011)
"The case of a patient with recurrent esthesioneuroblastoma complicated by ectopic adrenocorticotropic hormone production is presented, including the workup and management of this uncommon complication of an uncommon disease."1.36Esthesioneuroblastoma (Olfactory Neuroblastoma) with Ectopic ACTH Syndrome: a multidisciplinary case presentation from the Joan Karnell cancer center of Pennsylvania Hospital. ( Benito, M; Mintzer, DM; Nagamine, M; Newman, J; Zheng, S, 2010)
"Being best-studied superficial bladder cancer (SBC) chemopreventives, retinoids' negative studies and toxicity were stumbling."1.35The effectiveness of retinoic acid treatment in bladder cancer: impact on recurrence, survival and TGFalpha and VEGF as end-point biomarkers. ( el-Metwally, TH; Hameed, DA, 2008)

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19901 (7.14)18.7374
1990's1 (7.14)18.2507
2000's5 (35.71)29.6817
2010's6 (42.86)24.3611
2020's1 (7.14)2.80

Authors

AuthorsStudies
Özhan, B1
Yıldırım Çakar, D1
Gülten, G1
Yalçın, N1
Espinosa-de-Los-Monteros, AL1
Sosa-Eroza, E1
Espinosa, E1
Mendoza, V1
Arreola, R1
Mercado, M1
Kast, RE1
Boockvar, JA1
Brüning, A1
Cappello, F1
Chang, WW1
Cvek, B1
Dou, QP1
Duenas-Gonzalez, A1
Efferth, T1
Focosi, D1
Ghaffari, SH1
Karpel-Massler, G1
Ketola, K1
Khoshnevisan, A1
Keizman, D1
Magné, N1
Marosi, C1
McDonald, K1
Muñoz, M1
Paranjpe, A1
Pourgholami, MH1
Sardi, I1
Sella, A1
Srivenugopal, KS1
Tuccori, M1
Wang, W1
Wirtz, CR1
Halatsch, ME1
Seneviratne, CJ1
Fong, PH1
Wong, SS1
Lee, VH1
Sheng, L1
Anderson, PH1
Turner, AG1
Pishas, KI1
Dhatrak, DJ1
Gill, PG1
Morris, HA1
Callen, DF1
Aghi, MK1
Mintzer, DM1
Zheng, S1
Nagamine, M1
Newman, J1
Benito, M1
Paz Moreno-Arrones, J1
Montes-Mollón, MÁ1
Zimmerman, RA1
Culkin, DJ1
Carmona-Bayonas, A1
Soler, IO1
Gómez, FI1
Billalabeitia, EG1
Saura, HP1
Tafalla, MS1
Díaz, MP1
Hameed, DA1
el-Metwally, TH1
Lotan, Y1
Lotan, R1
Mahler, C1
Verhelst, J1
Denis, L1
Sinnaeve, LJ1
Becks, GP1

Reviews

4 reviews available for ketoconazole and Local Neoplasm Recurrence

ArticleYear
A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care.
    Oncotarget, 2013, Volume: 4, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Artemisinins; Auranofin; Brain Neoplasms

2013
Management of recurrent and refractory Cushing disease.
    Nature clinical practice. Endocrinology & metabolism, 2008, Volume: 4, Issue:10

    Topics: ACTH-Secreting Pituitary Adenoma; Adrenalectomy; Humans; Hypophysectomy; Ketoconazole; Models, Biolo

2008
Clinical strategies in the management of biochemical recurrence after radical prostatectomy.
    Clinical prostate cancer, 2003, Volume: 2, Issue:3

    Topics: Androgen Antagonists; Antifungal Agents; Cytochrome P-450 Enzyme System; Disease-Free Survival; Flut

2003
Ketoconazole and liarozole in the treatment of advanced prostatic cancer.
    Cancer, 1993, Feb-01, Volume: 71, Issue:3 Suppl

    Topics: Aged; Aged, 80 and over; Androgen Antagonists; Glucocorticoids; Humans; Imidazoles; Ketoconazole; Ma

1993

Trials

1 trial available for ketoconazole and Local Neoplasm Recurrence

ArticleYear
Ketoconazole and liarozole in the treatment of advanced prostatic cancer.
    Cancer, 1993, Feb-01, Volume: 71, Issue:3 Suppl

    Topics: Aged; Aged, 80 and over; Androgen Antagonists; Glucocorticoids; Humans; Imidazoles; Ketoconazole; Ma

1993

Other Studies

10 other studies available for ketoconazole and Local Neoplasm Recurrence

ArticleYear
An exceptionally rare case of Cushing's syndrome caused by ectopic ACTH syndrome due to olfactory neuroblastoma in childhood.
    Journal of pediatric endocrinology & metabolism : JPEM, 2023, May-25, Volume: 36, Issue:5

    Topics: ACTH Syndrome, Ectopic; Adrenocorticotropic Hormone; Child; Child, Preschool; Cushing Syndrome; Esth

2023
LONG-TERM OUTCOME OF THE DIFFERENT TREATMENT ALTERNATIVES FOR RECURRENT AND PERSISTENT CUSHING DISEASE.
    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2017, Volume: 23, Issue:7

    Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Adolescent; Adrenalectomy; Adult; Antifungal Agents; Coho

2017
Antifungal susceptibility and phenotypic characterization of oral isolates of a black fungus from a nasopharyngeal carcinoma patient under radiotherapy.
    BMC oral health, 2015, Mar-20, Volume: 15

    Topics: Amphotericin B; Antifungal Agents; Biofilms; Carcinoma; Caspofungin; Chemoradiotherapy; Chemotherapy

2015
Identification of vitamin D
    The Journal of steroid biochemistry and molecular biology, 2016, Volume: 164

    Topics: Antineoplastic Agents; Breast; Breast Neoplasms; Calcitriol; Cell Adhesion; Cell Line, Tumor; Cholec

2016
Esthesioneuroblastoma (Olfactory Neuroblastoma) with Ectopic ACTH Syndrome: a multidisciplinary case presentation from the Joan Karnell cancer center of Pennsylvania Hospital.
    The oncologist, 2010, Volume: 15, Issue:1

    Topics: ACTH Syndrome, Ectopic; Adrenocorticotropic Hormone; Anti-Inflammatory Agents; Antifungal Agents; An

2010
[Bilateral conjunctival oedema as a symptom of adrenal adenocarcinoma].
    Archivos de la Sociedad Espanola de Oftalmologia, 2011, Volume: 86, Issue:6

    Topics: Adenocarcinoma; Adrenal Cortex Neoplasms; Adrenalectomy; Aged; Antineoplastic Combined Chemotherapy

2011
Tailored hormonal therapy in secretory adrenocortical cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2007, Volume: 18, Issue:7

    Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Aged; Aldosterone; Alkalosis; Ang

2007
The effectiveness of retinoic acid treatment in bladder cancer: impact on recurrence, survival and TGFalpha and VEGF as end-point biomarkers.
    Cancer biology & therapy, 2008, Volume: 7, Issue:1

    Topics: Aged; Biomarkers; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Humans; Ketoconazole; M

2008
Prevention of bladder cancer recurrence by retinoic acid-ketoconazole: a promising strategy?
    Cancer biology & therapy, 2008, Volume: 7, Issue:1

    Topics: Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Drug Therapy, Combination; Humans; Ketoconaz

2008
Preoperative ketoconazole therapy for adrenocortical carcinoma.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1989, Jul-15, Volume: 141, Issue:2

    Topics: Adrenal Cortex Neoplasms; Carcinoma; Combined Modality Therapy; Drug Evaluation; Female; Humans; Ket

1989